News
In a retrospective analysis of patients who received peptide vaccines via n-of-1 programs, 89 percent had immune reactions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback